CompletedNot Applicable

Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes

Bosnia and Herzegovina400 participantsStarted 2007-12

Plain-language summary

This trial is conducted in Europe. The aim of this observational study is to evaluate the glycaemic control in patients with type 1 or 2 diabetes using NovoMix® 30 or Levemir® under normal clinical practice conditions.

Who can participate

Age range6 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with Type 1 or Type 2 diabetes, including newly diagnosed * Age: Levemir® above 6 years * Age: Novomix® above 18 years Exclusion Criteria: * Current treatment with NovoMix® 30 or Levemir®

What they're measuring

Glycaemic control as measured by HbA1c

Timeframe: After 24 weeks

Trial details

NCT IDNCT00671008

SponsorNovo Nordisk A/S

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2008-09

View on ClinicalTrials.gov More Diabetes trials